Loading clinical trials...
Loading clinical trials...
Ranibizumab has proven to be of benefit to improve the perfusion in the retina of patients with Choroidal Melanoma. The investigators consider that higher doses of Ranibizumab can help reduce the numb...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
New England Retina Associates
Collaborators
NCT06007690 · Choroidal Melanoma, Indeterminate Lesions, and more
NCT03941379 · Choroidal Melanoma, Indeterminate Lesions of Eye
NCT01334008 · Choroidal Melanoma, Diffuse
NCT04417530 · Uveal Melanoma, Ocular Melanoma, and more
NCT03052127 · Uveal Melanoma, Ocular Melanoma, and more
New England Retina Associates
Hamden, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions